Overview

Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis

Status:
Terminated
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether combination therapy with sildenafil and losartan can improve function and exercise tolerance in patients with idiopathic pulmonary fibrosis.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Alicia Gerke
University of Iowa
Collaborator:
Pulmonary Fibrosis Foundation
Treatments:
Losartan
Sildenafil Citrate